» Articles » PMID: 36582371

Ethical Allocation of Scarce Vaccine Doses: The Priority-Equality Protocol

Overview
Specialty Public Health
Date 2022 Dec 30
PMID 36582371
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whenever vaccines for a new pandemic or widespread epidemic are developed, demand greatly exceeds the available supply of vaccine doses in the crucial, initial phases of vaccination. Rationing protocols must then fulfill a number of ethical principles balancing equal treatment of individuals and prioritization of at-risk and instrumental subpopulations. For COVID-19, actual rationing methods used a territory-based first allocation stage based on proportionality to population size, followed by locally-implemented prioritization rules. The results of this procedure have been argued to be ethically problematic.

Methods: We use a formal-analytical approach arising from the mathematical social sciences which allows to investigate whether any allocation methods (known or unknown) fulfill a combination of (ethical) desiderata and, if so, how they are formulated algorithmically.

Results: Strikingly, we find that there exists one and only one method that allows to treat people equally while giving priority to those who are worse off. We identify this method down to the algorithmic level and show that it is easily implementable and it exhibits additional, desirable properties. In contrast, we show that the procedures used during the COVID-19 pandemic violate both principles.

Conclusions: Our research delivers an actual algorithm that is readily applicable and improves upon previous ones. Since our axiomatic approach shows that any other algorithm would either fail to treat people equally or fail to prioritize those who are worse off, we conclude that ethical principles dictate the adoption of this algorithm as a standard for the COVID-19 or any other comparable vaccination campaigns.

Citing Articles

Policy uptake and implementation of the RTS,S/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation.

Osoro C, Ochodo E, Kwambai T, Otieno J, Were L, Sagam C BMJ Glob Health. 2024; 9(4).

PMID: 38688566 PMC: 11085798. DOI: 10.1136/bmjgh-2023-014719.

References
1.
Pilkington V, Keestra S, Hill A . Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future. Front Public Health. 2022; 10:821117. PMC: 8936388. DOI: 10.3389/fpubh.2022.821117. View

2.
Lavazza A, Garasic M . What if some patients are more "important" than others? A possible framework for Covid-19 and other emergency care situations. BMC Med Ethics. 2022; 23(1):24. PMC: 8918089. DOI: 10.1186/s12910-022-00763-2. View

3.
Emanuel E, Persad G, Upshur R, Thome B, Parker M, Glickman A . Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med. 2020; 382(21):2049-2055. DOI: 10.1056/NEJMsb2005114. View

4.
Jecker N, Atuire C, Bull S . Towards a new model of global health justice: the case of COVID-19 vaccines. J Med Ethics. 2022; 49(5):367-374. PMC: 9072783. DOI: 10.1136/medethics-2022-108165. View

5.
Baltussen R, Niessen L . Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Resour Alloc. 2006; 4:14. PMC: 1560167. DOI: 10.1186/1478-7547-4-14. View